High-density Lipoprotein Cholesterol Levels and Prognosis in Advanced Heart Failure

Journal of Heart and Lung Transplantation

Volumn 28, Issue 9, 2009, Pages 876-880

  Mehra, Mandeep R ^a   Uber, Patricia A ^a   Lavie, Carl J ^b   Milani, Richard V ^b   Park, Myung H ^a   Ventura, Hector O ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b OCHSNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; CREATININE; CYCLOOXYGENASE 2; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTACYCLIN; SODIUM; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SURVIVAL RATE; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL;

ADULT; BILIRUBIN; CHOLESTEROL, HDL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67651188240     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.04.026     Document Type: Article

References (17)

1. Kalantar-Zadeh K., Block G., Horwich T., and Fonarow G.C. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43 (2004) 1439-1444
2. Lavie C.J., and Milani R.V. Shedding light on high-density lipoprotein cholesterol: the post-ILLUMINATE era. J Am Coll Cardiol 51 (2008) 56-58
3. Rauchhaus M., Clark A.L., Doehner W., et al. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 42 (2003) 1933-1940
4. Horwich T.B., Hamilton M.A., Maclellan W.R., and Fonarow G.C. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 8 (2002) 216-224
5. Sharma R., von Haehling S., Rauchhaus M., et al. Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins. Eur J Heart Fail 7 (2005) 479-484
6. Kjekshus J., Apetrei E., Barrios V., et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357 (2007) 2248-2261
7. Tavazzi L., Maggioni A.P., Marchioli R., et al. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372 (2008) 1231-1239
8. Cockerill G.W., Rye K.A., Gamble J.R., Vadas M.A., and Barter P.J. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 15 (1995) 1987-1994
9. Cockerill G.W., Saklatvala J., Ridley S.H., et al. High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2. Arterioscler Thromb Vasc Biol 19 (1999) 910-917
10. Viñals M., Martínez-González J., Badimon J.J., and Badimon L. HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2). Arterioscler Thromb Vasc Biol 17 (1997) 3481-3488
11. Vredevoe D.L., Woo M.A., Doering L.V., Brecht M.L., Hamilton M.A., and Fonarow G.C. Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 82 (1998) 323-328
12. Dzau V.J. Vascular and renal prostaglandins as counter-regulatory systems in heart failure. Eur Heart J 9 suppl H (1988) 15-19
13. Dzau V.J., Packer M., Lilly L.S., Swartz S.L., Hollenberg N.K., and Williams G.H. Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med 310 (1984) 347-352
14. Meune C., Mourad J.J., Bergmann J.F., and Spaulding C. Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance. J Renin-Angiotensin-Aldosterone Syst 4 (2003) 149-154
15. Dhingra R., Sesso H.D., Kenchaiah S., and Gaziano J.M. Differential effects of lipids on the risk of heart failure and coronary heart disease: the Physicians' Health Study. Am Heart J 155 (2008) 869-875
16. Landi F., Russo A., and Pahor M. Serum high-density lipoprotein cholesterol levels and mortality in frail, community-living elderly. Gerontology 54 (2008) 71-78
17. Iwaoka M., Obata J.E., Abe M., et al. Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure. J Card Fail 13 (2007) 247-253